Welcome to our Global website select your language en 中文 OR select country-specific content... This website would like to use cookies to store information on your computer which will help to customize your interactions with us and provide you with a better browsing experience. You may delete and block cookies from this site, but parts of the site may not function as a result. More information about cookies and your choices can be found in our Privacy Policy. To accept cookies from this site, please click the "I Accept" button below. I ACCEPT I DECLINE .cls-1-new{fill:#6d6e71;}.cls-2-new{fill:#d82c2a;}.cls-3-new{fill:#009367;} Products & Services Support Contact Us News & Events About Us Careers Log In Global Search Collaboration to launch breakthrough cancer immnotherapy treatment in Europe. Learn more 1234567 QUICK LINKS Get Product Support Find Technical Documents Find Certificates of Compliance Get Training Start a Career With Us Distributor News Modern Slavery Act Statement LATEST NEWS Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe Terumo Blood and Cell Technologies Opens Manufacturing Facility in Costa Rica Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare Terumo Blood and Cell Technologies announces a new software update for its Finia® Fill and Finish System as the cell and gene therapy industry evolves toward automation Terumo Blood and Cell Technologies and PhotonPharma, Inc. announce collaboration to develop a novel cancer immunotherapy Peer-reviewed study in Africa Sanguine shows positive health economic impact and reduced maternal mortality rate for countries investing in blood transfusion to save lives of African mothers The Spectra Optia® Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT System can now be used to provide extracorporeal photopheresis immunotherapy Terumo Blood and Cell Technologies Joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium .cls-1-new{fill:#6d6e71;}.cls-2-new{fill:#d82c2a;}.cls-3-new{fill:#009367;} Products available in select markets. Contract Manufacturing Careers Employee Resources Research & Grants Advancing Apheresis Award Privacy Policy Terms and Conditions Site Map ©2020 TERUMO BCT, INC. ALL RIGHTS RESERVED